Hinna Askell, Steiniger Frank, Hupfeld Stefan, Brandl Martin, Kuntsche Judith
Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230, Odense, Denmark.
Anal Bioanal Chem. 2014 Dec;406(30):7827-39. doi: 10.1007/s00216-014-7643-9. Epub 2014 Feb 12.
Knowledge about drug retention within colloidal carriers is of uppermost importance particularly if drug targeting is anticipated. The aim of the present study was to evaluate asymmetrical flow field-flow fractionation (AF4) with on-line UV/VIS drug quantification for its suitability to determine both release and transfer of drug from liposomal carriers to a model acceptor phase consisting of large liposomes. The hydrophobic porphyrin 5,10,15,20-tetrakis(4-hydroxyphenyl)21H,23H-porphine (p-THPP), a fluorescent dye with an absorbance maximum in the visible range and structural similarity to the clinically used photosensitizer temoporfin, was used as a model drug, and two types of large liposomes were studied as a potential model acceptor phase. Efficiency of separation of small donor from large acceptor liposomes by AF4 was evaluated in dependence on the injected lipid mass using two different channel geometries. Drug quantification by on-line absorbance measurements was established by comprehensive evaluation of the size-dependent turbidity contribution in on-line UV/VIS detection and by comparison with off-line results obtained for the respective dye-loaded donor formulations (dissolved in methanol). Due to distinct differences in size, the acceptor liposomes (mean diameters ∼300-400 nm) could efficiently be separated from the donor liposomes (mean diameter ∼70 nm) with less than 4 % of p-THPP detected in the overlap region between both vesicle populations. Whereas p-THPP could accurately be determined in the fraction of small vesicles, on-line quantification was impaired in the fraction of the large acceptor liposomes due to the pronounced contribution of turbidity (about 80 % of total UV/VIS extinction signal). The AF4-based release/transfer approach suggested here was found repeatable and robust. The employed combination of AF4 with multi-angle laser light scattering furthermore provided detailed size information of the eluting sample and thus allowed to detect instabilities and/or interactions between the donor and acceptor liposomes. Drug quantification by on-line absorbance measurements was found feasible for the chosen model drug, but careful (re-)evaluation of turbidity effects is crucial for other drug and carrier combinations.
了解药物在胶体载体中的保留情况至关重要,尤其是在预期进行药物靶向时。本研究的目的是评估在线紫外/可见药物定量分析的不对称流场-流分级法(AF4),以确定其是否适合测定药物从脂质体载体释放并转移到由大脂质体组成的模型接受相的情况。疏水性卟啉5,10,15,20-四(4-羟苯基)21H,23H-卟吩(p-THPP)是一种在可见光范围内具有最大吸收的荧光染料,其结构与临床使用的光敏剂替莫泊芬相似,用作模型药物,并研究了两种类型的大脂质体作为潜在的模型接受相。使用两种不同的通道几何形状,根据注入的脂质质量评估了AF4从小供体脂质体中分离大受体脂质体的效率。通过全面评估在线紫外/可见检测中与尺寸相关的浊度贡献,并与相应载有染料的供体制剂(溶解在甲醇中)的离线结果进行比较,建立了通过在线吸光度测量进行药物定量的方法。由于尺寸存在明显差异,受体脂质体(平均直径约300-400 nm)能够有效地与供体脂质体(平均直径约70 nm)分离,在两个囊泡群体的重叠区域中检测到的p-THPP不到4%。虽然可以在小囊泡部分准确测定p-THPP,但由于浊度的显著贡献(约占总紫外/可见消光信号的80%),在线定量在大受体脂质体部分受到影响。这里提出的基于AF4的释放/转移方法具有可重复性和稳健性。AF4与多角度激光光散射的联用还提供了洗脱样品的详细尺寸信息,从而能够检测供体和受体脂质体之间的不稳定性和/或相互作用。对于所选的模型药物,通过在线吸光度测量进行药物定量是可行的,但对于其他药物和载体组合,仔细(重新)评估浊度影响至关重要。